🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
4.840
-0.270 (-5.28%)
At close: Nov 19, 2026, 4:00 PM EST
4.840
0.00 (0.00%)
After-hours: Nov 19, 2026, 4:15 PM EST

Aethlon Medical Statistics

Total Valuation

Aethlon Medical has a market cap or net worth of $7.78 million. The enterprise value is $1.47 million.

Market Cap7.78M
Enterprise Value 1.47M

Important Dates

The last earnings date was Thursday, November 12, 2026, after market close.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

Aethlon Medical has 1.61 million shares outstanding. The number of shares has increased by 837.95% in one year.

Current Share Class 711,136
Shares Outstanding 1.61M
Shares Change (YoY) +837.95%
Shares Change (QoQ) +161.90%
Owned by Insiders (%) 0.51%
Owned by Institutions (%) 9.79%
Float 314,240

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.36
P/TBV Ratio 1.36
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.37, with a Debt / Equity ratio of 0.03.

Current Ratio 5.37
Quick Ratio 5.07
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -573.73

Financial Efficiency

Return on equity (ROE) is -136.76% and return on invested capital (ROIC) is -82.37%.

Return on Equity (ROE) -136.76%
Return on Assets (ROA) -70.33%
Return on Invested Capital (ROIC) -82.37%
Return on Capital Employed (ROCE) -136.23%
Weighted Average Cost of Capital (WACC) 10.94%
Revenue Per Employee n/a
Profits Per Employee -$896,437
Employee Count9
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -76.95% in the last 52 weeks. The beta is 1.23, so Aethlon Medical's price volatility has been higher than the market average.

Beta (5Y) 1.23
52-Week Price Change -76.95%
50-Day Moving Average 5.39
200-Day Moving Average 7.21
Relative Strength Index (RSI) 40.23
Average Volume (20 Days) 32,350

Short Selling Information

The latest short interest is 43,186, so 2.69% of the outstanding shares have been sold short.

Short Interest 43,186
Short Previous Month 32,925
Short % of Shares Out 2.69%
Short % of Float 13.74%
Short Ratio (days to cover) 0.71

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -8.25M
Pretax Income -8.07M
Net Income -8.07M
EBITDA -7.93M
EBIT -8.25M
Earnings Per Share (EPS) -$17.80
Full Income Statement

Balance Sheet

The company has $6.49 million in cash and $172,116 in debt, with a net cash position of $6.31 million or $3.93 per share.

Cash & Cash Equivalents 6.49M
Total Debt 172,116
Net Cash 6.31M
Net Cash Per Share $3.93
Equity (Book Value) 6.05M
Book Value Per Share 3.77
Working Capital 5.58M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.26 million and capital expenditures -$15,019, giving a free cash flow of -$7.27 million.

Operating Cash Flow -7.26M
Capital Expenditures -15,019
Depreciation & Amortization 314,160
Net Borrowing n/a
Free Cash Flow -7.27M
FCF Per Share -$4.52
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Aethlon Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -837.95%
Shareholder Yield -837.95%
Earnings Yield -367.83%
FCF Yield -88.54%

Analyst Forecast

The average price target for Aethlon Medical is $13.25, which is 173.76% higher than the current price. The consensus rating is "Hold".

Price Target $13.25
Price Target Difference 173.76%
Analyst Consensus Hold
Analyst Count 2
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on August 4, 2026. It was a reverse split with a ratio of 1:5.

Last Split Date Aug 4, 2026
Split Type Reverse
Split Ratio 1:5

Scores

Altman Z-Score n/a
Piotroski F-Score 2